| dc.creator |
Cerci, Sureyya |
|
| dc.creator |
Gurnus, Burcin |
|
| dc.creator |
Yildiz, Mustafa |
|
| dc.creator |
Soyupek, Feray |
|
| dc.creator |
Yidiz, Sedat |
|
| dc.date |
2007-08-31T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T11:23:49Z |
|
| dc.date.available |
2020-10-06T11:23:49Z |
|
| dc.identifier |
cc456b86-ac65-441b-917b-6893a7b3c33d |
|
| dc.identifier |
10.1007/s12011-007-0034-8 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/cc456b86-ac65-441b-917b-6893a7b3c33d/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/72235 |
|
| dc.description |
The relationship between plasma levels of homocysteine (Hcy) and femur bone mineral density (BMD) was studied in Wistar rats. After 8 weeks of treatment with 0.5 and 1.0 g kg(-1) day(-1) L-methionine the mean plasma levels of Hey were 7.67+/-1.25 and 61.2+/-11.4 mu mol/l, respectively. Only rats treated with the higher dose had Hey levels significantly higher than those of controls, 6.38+/-0.90 mu mol/l (p<0.001). Dual Energy X-ray Absotptiometry was used to measure the BMD, which was significantly lower only in the animals with the highest plasma levels of Hey (p<0.001). This led us to conclude that increased levels of Hcy are associated with risk of decreased BMD. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Effect of homocysteine on bone mineral density of rats |
|
| dc.type |
info:eu-repo/semantics/article |
|